Psychoneurobiology Research and Personalized Treatment of Schizophrenia
Schizophrenia is a common disease characterized by psychotic symptoms (e.g., delusion, hallucinations, blunted affect) and disturbances of cognitive function (e.g., memory, abstraction, attention). If not treated properly, patients may experience serious consequences in terms of social function. Muc...
Saved in:
Other Authors: | |
---|---|
Format: | Electronic Book Chapter |
Language: | English |
Published: |
Basel
MDPI - Multidisciplinary Digital Publishing Institute
2022
|
Subjects: | |
Online Access: | DOAB: download the publication DOAB: description of the publication |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000naaaa2200000uu 4500 | ||
---|---|---|---|
001 | doab_20_500_12854_78772 | ||
005 | 20220224 | ||
003 | oapen | ||
006 | m o d | ||
007 | cr|mn|---annan | ||
008 | 20220224s2022 xx |||||o ||| 0|eng d | ||
020 | |a books978-3-0365-2858-8 | ||
020 | |a 9783036528588 | ||
020 | |a 9783036528595 | ||
040 | |a oapen |c oapen | ||
024 | 7 | |a 10.3390/books978-3-0365-2858-8 |c doi | |
041 | 0 | |a eng | |
042 | |a dc | ||
072 | 7 | |a M |2 bicssc | |
100 | 1 | |a Sumiyoshi, Tomiki |4 edt | |
700 | 1 | |a Sumiyoshi, Tomiki |4 oth | |
245 | 1 | 0 | |a Psychoneurobiology Research and Personalized Treatment of Schizophrenia |
260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2022 | ||
300 | |a 1 electronic resource (133 p.) | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
520 | |a Schizophrenia is a common disease characterized by psychotic symptoms (e.g., delusion, hallucinations, blunted affect) and disturbances of cognitive function (e.g., memory, abstraction, attention). If not treated properly, patients may experience serious consequences in terms of social function. Much endeavor in several disciplines of medical science has been made to overcome the paucity of effective treatments for unmet needs, including cognitive impairment associated with schizophrenia.This Book, contributed by experts from various regions of the globe, provides up-to-date information to facilitate the development of personal therapeutics for this enigmatic illness. | ||
540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
546 | |a English | ||
650 | 7 | |a Medicine |2 bicssc | |
653 | |a first-episode psychosis | ||
653 | |a metacognitive training | ||
653 | |a cognitive insight | ||
653 | |a sessions | ||
653 | |a experiment | ||
653 | |a magnetic resonance imaging | ||
653 | |a schizophrenia | ||
653 | |a schizotypal disorder | ||
653 | |a gyrification | ||
653 | |a superior temporal gyrus | ||
653 | |a neurodevelopment | ||
653 | |a cannabis | ||
653 | |a proteomics | ||
653 | |a olfactory neuroepithelium | ||
653 | |a metabolism | ||
653 | |a RNA | ||
653 | |a ZNF326 | ||
653 | |a MTREX | ||
653 | |a antipsychotics | ||
653 | |a body mass index | ||
653 | |a weight gain | ||
653 | |a metabolic syndrome | ||
653 | |a serotonin | ||
653 | |a genes | ||
653 | |a pharmacogenetics | ||
653 | |a mental disorders | ||
653 | |a developmental disorders | ||
653 | |a social cognition | ||
653 | |a social function | ||
653 | |a facial expression recognition | ||
653 | |a test battery | ||
653 | |a quality of life | ||
653 | |a systematic review | ||
653 | |a needs survey | ||
653 | |a neuromodulation | ||
653 | |a transcranial direct current stimulation (tDCS) | ||
653 | |a superior temporal sulcus | ||
653 | |a P300 | ||
653 | |a event-related potentials | ||
653 | |a clinical high-risk | ||
653 | |a psychosis | ||
653 | |a at risk mental state | ||
653 | |a cognition | ||
653 | |a latency | ||
653 | |a microglia | ||
653 | |a synaptic pruning | ||
653 | |a complement | ||
653 | |a CX3CR1 | ||
653 | |a medication | ||
653 | |a diagnosis | ||
653 | |a piccolo | ||
653 | |a presynaptic cytomatrix protein | ||
653 | |a medial prefrontal cortex | ||
653 | |a dorsal striatum | ||
653 | |a optogenetics | ||
653 | |a social functioning | ||
653 | |a n/a | ||
856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/4865 |7 0 |z DOAB: download the publication |
856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/78772 |7 0 |z DOAB: description of the publication |